2Dellinger RP, Carlet JIM, Masur H, et al. Surviving Sepsis Campaign Management Guidelines Committee. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004, 32:858-873.
3Tsai MH, Peng YS, Lien JM, et al. Multiple organ system failure in critically Ill cirrhotic patients. A comparison of two multiple organ dysfunction/failure scoring systems. Digestion, 2004, 69:190-200.
4Das UN. Insulin and the critically ill. Crit Care, 2002, 6:262-263.
5Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab, 2003,88:1082-1088.
6Yu WK, Li WQ, Li N, et al. Mononuclear histocompatibility leukocyte antigen-DR expression in the early phase of acute pancreatitis. Pancreatology, 2004, 27,4:233-243.
7Tschaikowsky K, Hedwig-Geissing M, Schiele A, et al. Coincidence of pro- and anti-inflammatory responses in the early phase of severe sepsis: longitudinal study of mononuclear histocompathtibility leukocyte antigen-DR expression, procalctonin, C-reactive protein, and changes in T-cell subsets in septic and postoperative patients. Crit Care Med, 2002,30:1015-1023.
8van den Berghe G, Wouters P, Weekers F,et al. Intensive insulin therapy in critically ill. N Engl J Med, 2001, 345:1359-1367.
9Netea MG, van der Meer JW, Kullberg BJ. Sepsis-theory and therapies. N Engl J Med, 2003, 348:1600-1602.
10American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.Crit Care Med, 1992,20:864-874.
